Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

Major depressive disorder (MDD) is a leading cause of disability worldwide. Current first line therapies target modulation of the monoamine system. A large variety of agents are currently available that effectively alter monoamine levels; however, approximately one third of MDD patients remain treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenblat, Christian, McIntyre, Roger S., Alves, Gilberto S., Fountoulakis, Konstantinos N., Carvalho, André F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761634/
https://www.ncbi.nlm.nih.gov/pubmed/26467412
http://dx.doi.org/10.2174/1570159X13666150630175044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761634/
https://www.ncbi.nlm.nih.gov/pubmed/26467412
http://dx.doi.org/10.2174/1570159X13666150630175044

Ejemplares similares